Listed

Anika Therapeutics, Inc.

ANIKNasdaqCIK 898437HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$32.6m, Q2 FY2026
Operating income$3.0m, Q2 FY2026
Net income$3.3m, Q2 FY2026
Anika Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m41.5Revenue, Q3 FY2023, three months to 2023-09-30$41.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure(2.9)Revenue, Q4 FY2023, three months to 2023-12-31−$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure29.0Revenue, Q1 FY2024, three months to 2024-03-31$29.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure30.7Revenue, Q2 FY2024, three months to 2024-06-30$30.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure29.6Revenue, Q3 FY2024, three months to 2024-09-30$29.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure30.6Revenue, Q4 FY2024, three months to 2024-12-31$30.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure26.2Revenue, Q1 FY2025, three months to 2025-03-31$26.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure28.2Revenue, Q2 FY2025, three months to 2025-06-30$28.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure27.8Revenue, Q3 FY2025, three months to 2025-09-30$27.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure30.6Revenue, Q4 FY2025, three months to 2025-12-31$30.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure29.6Revenue, Q1 FY2026, three months to 2026-03-31$29.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure32.6Revenue, Q2 FY2026, three months to 2026-06-30$32.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Cost of revenue$m16.5Cost of revenue, Q3 FY2023, three months to 2023-09-30$16.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure(8.7)Cost of revenue, Q4 FY2023, three months to 2023-12-31−$8.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure10.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$10.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure10.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$10.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure10.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$10.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure13.5Cost of revenue, Q4 FY2024, three months to 2024-12-31$13.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure11.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$11.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure13.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$13.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure12.2Cost of revenue, Q3 FY2025, three months to 2025-09-30$12.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure11.4Cost of revenue, Q4 FY2025, three months to 2025-12-31$11.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure10.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$10.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure11.4Cost of revenue, Q2 FY2026, three months to 2026-06-30$11.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Gross profit$m24.9Gross profit, Q3 FY2023, three months to 2023-09-30$24.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure5.8Gross profit, Q4 FY2023, three months to 2023-12-31$5.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure19.0Gross profit, Q1 FY2024, three months to 2024-03-31$19.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure20.5Gross profit, Q2 FY2024, three months to 2024-06-30$20.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure19.4Gross profit, Q3 FY2024, three months to 2024-09-30$19.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure17.1Gross profit, Q4 FY2024, three months to 2024-12-31$17.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure14.7Gross profit, Q1 FY2025, three months to 2025-03-31$14.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure14.4Gross profit, Q2 FY2025, three months to 2025-06-30$14.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure15.6Gross profit, Q3 FY2025, three months to 2025-09-30$15.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure19.2Gross profit, Q4 FY2025, three months to 2025-12-31$19.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure19.0Gross profit, Q1 FY2026, three months to 2026-03-31$19.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure21.2Gross profit, Q2 FY2026, three months to 2026-06-30$21.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Research and development$m7.8Research and development, Q3 FY2023, three months to 2023-09-30$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure(3.3)Research and development, Q4 FY2023, three months to 2023-12-31−$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure6.4Research and development, Q1 FY2024, three months to 2024-03-31$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure6.7Research and development, Q2 FY2024, three months to 2024-06-30$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure5.9Research and development, Q3 FY2024, three months to 2024-09-30$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure6.5Research and development, Q4 FY2024, three months to 2024-12-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure6.1Research and development, Q1 FY2025, three months to 2025-03-31$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure6.3Research and development, Q2 FY2025, three months to 2025-06-30$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure6.9Research and development, Q3 FY2025, three months to 2025-09-30$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure6.5Research and development, Q4 FY2025, three months to 2025-12-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure6.7Research and development, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure7.3Research and development, Q2 FY2026, three months to 2026-06-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Selling, general and administrative$m24.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$24.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure(15.6)Selling, general and administrative, Q4 FY2023, three months to 2023-12-31−$15.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure15.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$15.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure15.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$15.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure13.5Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$13.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure11.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$11.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure12.9Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$12.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure12.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$12.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure11.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$11.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure12.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$12.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure17.8Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$17.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure10.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$10.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Operating income$m(7.7)Operating income, Q3 FY2023, three months to 2023-09-30−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure24.7Operating income, Q4 FY2023, three months to 2023-12-31$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(2.5)Operating income, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure(1.8)Operating income, Q2 FY2024, three months to 2024-06-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure(0.1)Operating income, Q3 FY2024, three months to 2024-09-30−$81.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure(0.7)Operating income, Q4 FY2024, three months to 2024-12-31−$705.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(4.3)Operating income, Q1 FY2025, three months to 2025-03-31−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure(4.2)Operating income, Q2 FY2025, three months to 2025-06-30−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure(3.2)Operating income, Q3 FY2025, three months to 2025-09-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure0.6Operating income, Q4 FY2025, three months to 2025-12-31$646.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(5.5)Operating income, Q1 FY2026, three months to 2026-03-31−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure3.0Operating income, Q2 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Income tax$m(0.5)Income tax, Q3 FY2023, three months to 2023-09-30−$463.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure9.1Income tax, Q4 FY2023, three months to 2023-12-31$9.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$43.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure1.3Income tax, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure2.2Income tax, Q3 FY2024, three months to 2024-09-30$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure2.5Income tax, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2025-03-31$89.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure0.7Income tax, Q2 FY2025, three months to 2025-06-30$681.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure0.9Income tax, Q3 FY2025, three months to 2025-09-30$939.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure(1.0)Income tax, Q4 FY2025, three months to 2025-12-31−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2026, three months to 2026-03-31$235.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$71.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Net income$m(6.6)Net income, Q3 FY2023, three months to 2023-09-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure(63.0)Net income, Q4 FY2023, three months to 2023-12-31−$63.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Net income, Q1 FY2024, three months to 2024-03-31−$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure(0.1)Net income, Q2 FY2024, three months to 2024-06-30−$88.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure(29.9)Net income, Q3 FY2024, three months to 2024-09-30−$29.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure(21.9)Net income, Q4 FY2024, three months to 2024-12-31−$21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(4.9)Net income, Q1 FY2025, three months to 2025-03-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure(4.0)Net income, Q2 FY2025, three months to 2025-06-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure(2.3)Net income, Q3 FY2025, three months to 2025-09-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure0.3Net income, Q4 FY2025, three months to 2025-12-31$292.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(5.1)Net income, Q1 FY2026, three months to 2026-03-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure3.3Net income, Q2 FY2026, three months to 2026-06-30$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Diluted EPS$ per share(0.45)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure0.00Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure(2.03)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$2.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figurenot reported(0.34)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure(0.28)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure(0.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figurenot reported(0.37)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure0.24Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Basic EPS$ per share(0.45)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figurenot reported(0.31)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure(0.01)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure(2.03)Basic EPS, Q3 FY2024, three months to 2024-09-30−$2.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figurenot reported(0.34)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure(0.28)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure(0.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figurenot reported(0.37)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure0.25Basic EPS, Q2 FY2026, three months to 2026-06-30$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure

Balance sheet

Cash and equivalents$38.4m, Q2 FY2026
Shareholders' equity$137.3m, Q2 FY2026
Anika Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m70.7Cash and equivalents, Q3 FY2023, at 2023-09-30$70.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-03, accession 0001171843-23-006687.Report this figure68.7Cash and equivalents, FY2023, at 2023-12-31$68.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0001171843-25-001486.Report this figure68.6Cash and equivalents, Q1 FY2024, at 2024-03-31$68.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001171843-24-002682.Report this figure62.8Cash and equivalents, Q2 FY2024, at 2024-06-30$62.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001171843-24-004615.Report this figure62.4Cash and equivalents, Q3 FY2024, at 2024-09-30$62.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure55.6Cash and equivalents, FY2024, at 2024-12-31$55.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-03, accession 0001171843-26-001275.Report this figure53.4Cash and equivalents, Q1 FY2025, at 2025-03-31$53.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure53.2Cash and equivalents, Q2 FY2025, at 2025-06-30$53.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure58.0Cash and equivalents, Q3 FY2025, at 2025-09-30$58.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure57.5Cash and equivalents, FY2025, at 2025-12-31$57.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure41.0Cash and equivalents, Q1 FY2026, at 2026-03-31$41.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure38.4Cash and equivalents, Q2 FY2026, at 2026-06-30$38.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Current assets$m157Current assets, Q3 FY2023, at 2023-09-30$156.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001171843-23-006687.Report this figure163Current assets, FY2023, at 2023-12-31$163.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0001171843-25-001486.Report this figure159Current assets, Q1 FY2024, at 2024-03-31$159.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001171843-24-002682.Report this figure155Current assets, Q2 FY2024, at 2024-06-30$155.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001171843-24-004615.Report this figure136Current assets, Q3 FY2024, at 2024-09-30$136.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure114Current assets, FY2024, at 2024-12-31$113.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-03, accession 0001171843-26-001275.Report this figure103Current assets, Q1 FY2025, at 2025-03-31$102.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure99.3Current assets, Q2 FY2025, at 2025-06-30$99.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure102Current assets, Q3 FY2025, at 2025-09-30$101.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure103Current assets, FY2025, at 2025-12-31$103.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure93.6Current assets, Q1 FY2026, at 2026-03-31$93.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure99.2Current assets, Q2 FY2026, at 2026-06-30$99.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Total assets$m328Total assets, Q3 FY2023, at 2023-09-30$328.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001171843-23-006687.Report this figure271Total assets, FY2023, at 2023-12-31$270.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0001171843-25-001486.Report this figure264Total assets, Q1 FY2024, at 2024-03-31$263.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001171843-24-002682.Report this figure263Total assets, Q2 FY2024, at 2024-06-30$262.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001171843-24-004615.Report this figure231Total assets, Q3 FY2024, at 2024-09-30$231.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure203Total assets, FY2024, at 2024-12-31$202.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-03, accession 0001171843-26-001275.Report this figure191Total assets, Q1 FY2025, at 2025-03-31$190.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure188Total assets, Q2 FY2025, at 2025-06-30$187.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure189Total assets, Q3 FY2025, at 2025-09-30$189.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure190Total assets, FY2025, at 2025-12-31$190.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure179Total assets, Q1 FY2026, at 2026-03-31$179.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure183Total assets, Q2 FY2026, at 2026-06-30$183.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Current liabilities$m28.1Current liabilities, Q3 FY2023, at 2023-09-30$28.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001171843-23-006687.Report this figure31.1Current liabilities, FY2023, at 2023-12-31$31.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0001171843-25-001486.Report this figure28.5Current liabilities, Q1 FY2024, at 2024-03-31$28.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001171843-24-002682.Report this figure26.1Current liabilities, Q2 FY2024, at 2024-06-30$26.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001171843-24-004615.Report this figure25.5Current liabilities, Q3 FY2024, at 2024-09-30$25.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure23.3Current liabilities, FY2024, at 2024-12-31$23.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-03, accession 0001171843-26-001275.Report this figure17.9Current liabilities, Q1 FY2025, at 2025-03-31$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure16.1Current liabilities, Q2 FY2025, at 2025-06-30$16.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure19.1Current liabilities, Q3 FY2025, at 2025-09-30$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure21.9Current liabilities, FY2025, at 2025-12-31$21.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure21.0Current liabilities, Q1 FY2026, at 2026-03-31$21.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure22.1Current liabilities, Q2 FY2026, at 2026-06-30$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m270Shareholders' equity, Q3 FY2023, at 2023-09-30$270.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure212Shareholders' equity, FY2023, at 2023-12-31$212.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-03, accession 0001171843-26-001275.Report this figure209Shareholders' equity, Q1 FY2024, at 2024-03-31$208.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure210Shareholders' equity, Q2 FY2024, at 2024-06-30$210.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure180Shareholders' equity, Q3 FY2024, at 2024-09-30$179.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure154Shareholders' equity, FY2024, at 2024-12-31$154.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure148Shareholders' equity, Q1 FY2025, at 2025-03-31$148.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure148Shareholders' equity, Q2 FY2025, at 2025-06-30$147.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure147Shareholders' equity, Q3 FY2025, at 2025-09-30$146.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure143Shareholders' equity, FY2025, at 2025-12-31$143.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure134Shareholders' equity, Q1 FY2026, at 2026-03-31$133.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure137Shareholders' equity, Q2 FY2026, at 2026-06-30$137.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure

Cash flow

Operating cash flow−$684.0k, Q2 FY2026
Capital expenditure$1.4m, Q2 FY2026
Share repurchases$853.0k, Q2 FY2026
Anika Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k6,485Operating cash flow, Q3 FY2023, three months to 2023-09-30$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0001171843-24-005993. Derived: 9-month figure less the 6-month figure.Report this figure3,638Operating cash flow, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(126)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$126.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure(1,069)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001171843-25-004826. Derived: 6-month figure less the 3-month figure.Report this figure5,016Operating cash flow, Q3 FY2024, three months to 2024-09-30$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001171843-25-007032. Derived: 9-month figure less the 6-month figure.Report this figure1,582Operating cash flow, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(130)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$130.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure(189)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$189.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001171843-26-005012. Derived: 6-month figure less the 3-month figure.Report this figure6,870Operating cash flow, Q3 FY2025, three months to 2025-09-30$6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001171843-25-007032. Derived: 9-month figure less the 6-month figure.Report this figure4,637Operating cash flow, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure(4,846)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure(684)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$684.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001171843-26-005012. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k741Capital expenditure, Q3 FY2023, three months to 2023-09-30$741.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-04, accession 0001171843-24-005993. Derived: 9-month figure less the 6-month figure.Report this figure1,840Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure1,808Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure3,403Capital expenditure, Q2 FY2024, three months to 2024-06-30$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001171843-25-004826. Derived: 6-month figure less the 3-month figure.Report this figure1,216Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001171843-25-007032. Derived: 9-month figure less the 6-month figure.Report this figure1,307Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure2,824Capital expenditure, Q1 FY2025, three months to 2025-03-31$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure1,467Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001171843-26-005012. Derived: 6-month figure less the 3-month figure.Report this figure1,887Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001171843-25-007032. Derived: 9-month figure less the 6-month figure.Report this figure648Capital expenditure, Q4 FY2025, three months to 2025-12-31$648.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure1,431Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure1,449Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001171843-26-005012. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$k0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-04, accession 0001171843-24-005993. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure1,370Share repurchases, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-30, accession 0001171843-25-004826. Derived: 6-month figure less the 3-month figure.Report this figure3,969Share repurchases, Q3 FY2024, three months to 2024-09-30$4.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0001171843-25-007032. Derived: 9-month figure less the 6-month figure.Report this figure5,575Share repurchases, Q4 FY2024, three months to 2024-12-31$5.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure3,971Share repurchases, Q1 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-29, accession 0001171843-26-005012. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0001171843-25-007032. Derived: 9-month figure less the 6-month figure.Report this figure5,514Share repurchases, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-03, accession 0001171843-26-001275. Derived: 12-month figure less the 9-month figure.Report this figure8,690Share repurchases, Q1 FY2026, three months to 2026-03-31$8.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure853Share repurchases, Q2 FY2026, three months to 2026-06-30$853.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-29, accession 0001171843-26-005012. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)13.72m, Q2 FY2026
Anika Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares14.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3014,603,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001171843-23-006687.Report this figure14.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3114,653,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001171843-24-002682.Report this figure14.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3014,688,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001171843-24-004615.Report this figure14.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3014,635,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001171843-24-005993.Report this figure14.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3114,698,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001171843-25-003019.Report this figure14.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3014,856,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001171843-25-004826.Report this figure14.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3014,768,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure14.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3114,297,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure14.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3014,517,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure14.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3014,419,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001171843-25-007032.Report this figure13.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3113,531,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001171843-26-002852.Report this figure13.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3013,717,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure

Shares outstanding: 13.38mShares outstanding, period not labelled, at 2026-07-2413,382,966 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-29, accession 0001171843-26-005012.Report this figure at Jul 24, 2026, from the cover of the 10-Q filed Jul 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.